These knockout mice may become models for spondyloepimetaphyseal dysplasia and Meester-Loeys syndrome in human BGN deficiencies, and may be helpful for developing therapeutic agents for these disorders. This evidence concerns the gene BGN and spondyloepimetaphyseal dysplasia, matrilin-3 type.